October 2011 - Volume 17 - Issue 10
pp: 2027-2216,E128-E139
Subscribe to eTOC

Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease

Ng, S. C.; Benjamin, J. L.; McCarthy, N. E.; More

Inflammatory Bowel Diseases . 17(10):2027-2037, October 2011.

Colonic gene expression patterns of mucin muc2 knockout mice reveal various phases in colitis development1

Lu, Peng; Burger-van Paassen, Nanda; van der Sluis, Maria; More

Inflammatory Bowel Diseases . 17(10):2047-2057, October 2011.

Supplemental antioxidants do not ameliorate colitis development in HLA‐B27 transgenic rats despite extremely low glutathione levels in colonic mucosa5

Schepens, Marloes A.A.; Vink, Carolien; Schonewille, Arjan J.; More

Inflammatory Bowel Diseases . 17(10):2065-2075, October 2011.

DNFB‐DNS hapten‐induced colitis in mice should not be considered a model of inflammatory bowel disease5

Bailón, Elvira; Cueto-Sola, Margarita; Utrilla, Pilar; More

Inflammatory Bowel Diseases . 17(10):2087-2101, October 2011.

Distinguishing orofacial granulomatosis from crohn's disease: Two separate disease entities?1

Campbell, Helen; Escudier, Michael; Patel, Pritash; More

Inflammatory Bowel Diseases . 17(10):2109-2115, October 2011.

Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent crohn's disease1,2,3

Farraye, F. A.; Nimitphong, H.; Stucchi, A.; More

Inflammatory Bowel Diseases . 17(10):2116-2121, October 2011.

Expression of a soluble triggering receptor expressed on myeloid cells‐1 (sTREM‐1) correlates with clinical disease activity in intestinal Behcet's disease

Jung, Yoon Suk; Kim, Seung Won; Yoon, Jin Young; More

Inflammatory Bowel Diseases . 17(10):2130-2137, October 2011.

Long‐term outcome of treatment with infliximab in pediatric‐onset Crohn's disease: A population‐based study

Crombé, Valérie; Salleron, Julia; Savoye, Guillaume; More

Inflammatory Bowel Diseases . 17(10):2144-2152, October 2011.

Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease12

Long, Millie D.; Crandall, Wallace V.; Leibowitz, Ian H.; More

Inflammatory Bowel Diseases . 17(10):2162-2168, October 2011.

Identification ofMycobacterium cosmeticum sp. as a novel colitogenic infectious agent in a nonimmunocompromised patient

Boschetti, Gilles; Cotte, Eddy; Moussata, Driffa; More

Inflammatory Bowel Diseases . 17(10):E128-E130, October 2011.